Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-1463
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs ; day:16 ; month:1 ; year:2017 ; pages:1-9
Journal of neural transmission ; (16.1.2017), 1-9
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Urheber
-
Mizuno, Yoshikuni
- Beteiligte Personen und Organisationen
-
Shimoda, Satoe
Origasa, Hideki
SpringerLink (Online service)
- DOI
-
10.1007/s00702-016-1671-x
- URN
-
urn:nbn:de:1111-201702126844
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mizuno, Yoshikuni
- Shimoda, Satoe
- Origasa, Hideki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-term safety and efficacy of adjunctive rasagiline in levodopa-treated Japanese patients with Parkinson’s disease
Comparative efficacy and safety of adjunctive drugs to levodopa for fluctuating Parkinson’s disease - network meta-analysis
Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Charakteristika der Unified Parkinson’s Disease Rating Scale im Rahmen der Levodopa-Response
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Long-term safety and efficacy of adjunctive rasagiline in levodopa-treated Japanese patients with Parkinson’s disease
Comparative efficacy and safety of adjunctive drugs to levodopa for fluctuating Parkinson’s disease - network meta-analysis
Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Charakteristika der Unified Parkinson’s Disease Rating Scale im Rahmen der Levodopa-Response
Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson’s Disease?
Long-term safety and efficacy of adjunctive rasagiline in levodopa-treated Japanese patients with Parkinson’s disease
Comparative efficacy and safety of adjunctive drugs to levodopa for fluctuating Parkinson’s disease - network meta-analysis
Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Charakteristika der Unified Parkinson’s Disease Rating Scale im Rahmen der Levodopa-Response